Quest Diagnostics Incorporated – NYSE:DGX
Quest Diagnostics Incorporated stock price today
$182.83
+30.20
+19.79%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 2 hours
Quest Diagnostics Incorporated stock price monthly change
+5.91%
month
Quest Diagnostics Incorporated stock price quarterly change
+5.91%
quarter
Quest Diagnostics Incorporated stock price yearly change
+10.94%
year
Quest Diagnostics Incorporated key metrics
Market Cap | 16.95B |
Enterprise value | 23.24B |
P/E | 20.32 |
EV/Sales | 2.43 |
EV/EBITDA | 13.05 |
Price/Sales | 1.78 |
Price/Book | 2.51 |
PEG ratio | 51.32 |
EPS | 7.53 |
Revenue | 9.28B |
EBITDA | 1.77B |
Income | 846M |
Revenue Q/Q | 1.50% |
Revenue Y/Y | -3.29% |
Profit margin | 8.82% |
Oper. margin | 13.94% |
Gross margin | 32.31% |
EBIT margin | 13.94% |
EBITDA margin | 19.07% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeQuest Diagnostics Incorporated stock price history
Quest Diagnostics Incorporated stock forecast
Quest Diagnostics Incorporated financial statements
Average Price Target
$173.83
Potential downside: -4.92%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 2.33B | 235M | 10.05% |
|---|---|---|---|
| Sep 2023 | 2.29B | 225M | 9.8% |
| Dec 2023 | 2.28B | 192M | 8.39% |
| Mar 2024 | 2.36B | 194M | 8.2% |
1.93%
Yield TTM
| Payout ratio | 38.88% |
|---|
| 2019 | 2% |
|---|---|
| 2020 | 1.86% |
| 2021 | 1.43% |
| 2022 | 1.68% |
| 2023 | 2.03% |
| Jun 2023 | 13425000000 | 7.06B | 52.6% |
|---|---|---|---|
| Sep 2023 | 13482000000 | 6.94B | 51.5% |
| Dec 2023 | 14022000000 | 7.60B | 54.23% |
| Mar 2024 | 13954000000 | 7.40B | 53.09% |
| Jun 2023 | 444M | -682M | 189M |
|---|---|---|---|
| Sep 2023 | 207M | -107M | -83M |
| Dec 2023 | 527M | -114M | 130M |
| Mar 2024 | 154M | -213M | -153M |
Quest Diagnostics Incorporated alternative data
What is mobile apps rank?
MyQuest for Patients
| Platform: | Android |
| Store: | Google Play  |
| Type: | Free |
| Market: | United States |
Category:
| Aug 2023 | 13 |
|---|---|
| Sep 2023 | 10 |
| Oct 2023 | 12 |
| Nov 2023 | 14 |
| Dec 2023 | 16 |
| Jan 2024 | 15 |
| Feb 2024 | 15 |
| Mar 2024 | 13 |
| Apr 2024 | 15 |
| May 2024 | 18 |
| Jun 2024 | 16 |
| Jul 2024 | 15 |
| Aug 2024 | 16 |
| Sep 2024 | 15 |
| Oct 2024 | 13 |
| Nov 2024 | 15 |
| Dec 2024 | 25 |
Category:
| Aug 2023 | 8 |
|---|---|
| Sep 2023 | 7 |
| Oct 2023 | 8 |
| Nov 2023 | 8 |
| Dec 2023 | 9 |
| Jan 2024 | 9 |
| Feb 2024 | 8 |
| Mar 2024 | 6 |
| Apr 2024 | 9 |
| May 2024 | 7 |
| Jun 2024 | 6 |
| Jul 2024 | 8 |
| Aug 2024 | 5 |
| Sep 2024 | 10 |
| Oct 2024 | 10 |
| Nov 2024 | 7 |
| Dec 2024 | 15 |
Quest Diagnostics Incorporated Social Media Accounts
What are followers?
+0.37%
month
| May 2025 | 11321 |
|---|---|
| Jul 2025 | 11540 |
| Aug 2025 | 11583 |
Quest Diagnostics
| 21 May 2023 | 55 |
|---|---|
| 28 May 2023 | 54 |
| 4 Jun 2023 | 54 |
| 11 Jun 2023 | 49 |
| 18 Jun 2023 | 72 |
| 25 Jun 2023 | 64 |
| 2 Jul 2023 | 70 |
| 9 Jul 2023 | 65 |
| 16 Jul 2023 | 74 |
| 23 Jul 2023 | 68 |
| 30 Jul 2023 | 65 |
| 6 Aug 2023 | 67 |
| 13 Aug 2023 | 72 |
| 20 Aug 2023 | 63 |
| 27 Aug 2023 | 64 |
| 3 Sep 2023 | 74 |
| 10 Sep 2023 | 58 |
| 17 Sep 2023 | 74 |
| 24 Sep 2023 | 71 |
| 1 Oct 2023 | 61 |
Quest Diagnostics Brands
| 12 Feb 2023 | 6 | 3 | 32 | 78 |
|---|---|---|---|---|
| 19 Feb 2023 | 5 | 6 | 36 | 69 |
| 26 Feb 2023 | 6 | 5 | 25 | 70 |
| 5 Mar 2023 | 0 | 4 | 35 | 61 |
| 12 Mar 2023 | 0 | 6 | 22 | 71 |
| 19 Mar 2023 | 0 | 7 | 23 | 55 |
| 26 Mar 2023 | 0 | 0 | 27 | 73 |
| 2 Apr 2023 | 5 | 7 | 33 | 73 |
| 9 Apr 2023 | 7 | 0 | 22 | 85 |
| 16 Apr 2023 | 0 | 0 | 20 | 85 |
| 23 Apr 2023 | 5 | 3 | 25 | 61 |
| 30 Apr 2023 | 6 | 0 | 27 | 86 |
| 7 May 2023 | 2 | 0 | 27 | 59 |
| 14 May 2023 | 3 | 2 | 20 | 73 |
| 21 May 2023 | 2 | 2 | 22 | 86 |
| 28 May 2023 | 4 | 2 | 27 | 90 |
| 4 Jun 2023 | 6 | 5 | 15 | 69 |
| 11 Jun 2023 | 0 | 0 | 29 | 76 |
| 18 Jun 2023 | 9 | 4 | 20 | 100 |
| 25 Jun 2023 | 5 | 0 | 34 | 78 |
Numbers represent search interest relative to the highest point on the chart for the given region and time.
A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.
What is job openings count?
| Aug 2023 | 1,699 | 128 | 547 |
|---|---|---|---|
| Sep 2023 | 1,834 | 22 | 594 |
| Oct 2023 | 1,558 | 133 | 572 |
| Nov 2023 | 1,713 | 98 | 573 |
| Dec 2023 | 1,775 | 91 | 584 |
| Jan 2024 | 1,732 | 59 | 583 |
| Feb 2024 | 1,672 | 64 | 507 |
| Apr 2024 | 1,845 | 130 | 433 |
| May 2024 | 1,816 | 82 | 537 |
| Jun 2024 | 1,915 | 107 | 573 |
| Jul 2024 | 1,902 | 75 | 475 |
| Dec 2024 | 1,836 | 72 | NaN |
| Jan 2025 | 1,832 | 149 | NaN |
| Feb 2025 | 1,894 | 148 | NaN |
| Aug 2023 | 40,000 |
|---|---|
| Sep 2023 | 40,000 |
| Oct 2023 | 40,000 |
| Nov 2023 | 50,000 |
| Dec 2023 | 50,000 |
| Jan 2024 | 50,000 |
| Feb 2024 | 50,000 |
| Mar 2024 | 40,000 |
| Apr 2024 | 40,000 |
| May 2024 | 50,000 |
| Jun 2024 | 50,000 |
| Jul 2024 | 50,000 |
Quest Diagnostics Incorporated other data
84.54%
+3.53%
of DGX is owned by hedge funds
825
+1
102.29M
-1.40M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2024 | 0 | 16337 |
| Apr 2024 | 0 | 1760 |
| Jul 2024 | 0 | 420 |
| Aug 2024 | 0 | 34541 |
| Oct 2024 | 0 | 1775 |
| Nov 2024 | 0 | 87004 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | PREVOZNIK MICHAEL E officer: SVP & Ge.. | Common Stock | 35,146 | $86.63 | $3,044,698 | ||
Sale | PREVOZNIK MICHAEL E officer: SVP & Ge.. | Common Stock | 3,009 | $162.26 | $488,237 | ||
Sale | PREVOZNIK MICHAEL E officer: SVP & Ge.. | Common Stock | 32,137 | $163.15 | $5,243,055 | ||
Option | PREVOZNIK MICHAEL E officer: SVP & Ge.. | Non-Qualifed Stock Option (right to buy) | 35,146 | $86.63 | $3,044,698 | ||
Option | DOHERTY CATHERINE T. officer: EVP, Regional Businesses | Common Stock | 33,103 | $103.57 | $3,428,478 | ||
Sale | DOHERTY CATHERINE T. officer: EVP, Regional Businesses | Common Stock | 4,803 | $162.14 | $778,778 | ||
Sale | DOHERTY CATHERINE T. officer: EVP, Regional Businesses | Common Stock | 28,300 | $163.14 | $4,616,721 | ||
Option | DOHERTY CATHERINE T. officer: EVP, Regional Businesses | Non-Qualifed Stock Option (right to buy) | 33,103 | $103.57 | $3,428,478 | ||
Option | DEPPE MICHAEL J officer: SVP, Cor.. | Common Stock | 10,120 | $66.51 | $673,081 | ||
Sale | DEPPE MICHAEL J officer: SVP, Cor.. | Common Stock | 2,100 | $152.7 | $320,676 |
| Quarter | Transcript |
|---|---|
| Q1 2024 23 Apr 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 1 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 24 Oct 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 26 Jul 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. Stephen H. Rusckowski (1957) Chairman, Pres & Chief Executive Officer | $4,300,000 |
Mr. James E. Davis (1963) Executive Vice President of Gen. Diagnostics | $1,440,000 |
| Ms. Carrie Eglinton Manner (1975) Senior Vice President of Advanced Diagnostics | $1,310,000 |
Quest Diagnostics: Buy Into Future Patient Demand At An Undervalued Price Today
Quest Diagnostics: A Leader But Waiting For Better Price
Natera: Poised For A Great Future But I'd Wait For A Pullback
Quest Diagnostics: Post-COVID Normalization Pretty Much Done
Quest Diagnostics: Healthier Diagnosis
23andMe Holding: At Risk Of Becoming Irrelevant
Quest Diagnostics Remains A Solid Long-Term Company
CVS Health: Acquisitions May Not Create True Value
Invitae Busted Business Model Offers A Tactical Opportunity
-
What's the price of Quest Diagnostics Incorporated stock today?
One share of Quest Diagnostics Incorporated stock can currently be purchased for approximately $182.83.
-
When is Quest Diagnostics Incorporated's next earnings date?
Unfortunately, Quest Diagnostics Incorporated's (DGX) next earnings date is currently unknown.
-
Does Quest Diagnostics Incorporated pay dividends?
Yes, Quest Diagnostics Incorporated pays dividends and its trailing 12-month yield is 1.94% with 39% payout ratio. The last Quest Diagnostics Incorporated stock dividend of $0.62 was paid on 2 Feb 2022.
-
How much money does Quest Diagnostics Incorporated make?
Quest Diagnostics Incorporated has a market capitalization of 16.95B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 6.38% to 9.25B US dollars.
-
What is Quest Diagnostics Incorporated's stock symbol?
Quest Diagnostics Incorporated is traded on the NYSE under the ticker symbol "DGX".
-
What is Quest Diagnostics Incorporated's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Quest Diagnostics Incorporated?
Shares of Quest Diagnostics Incorporated can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Quest Diagnostics Incorporated's key executives?
Quest Diagnostics Incorporated's management team includes the following people:
- Mr. Stephen H. Rusckowski Chairman, Pres & Chief Executive Officer(age: 68, pay: $4,300,000)
- Mr. James E. Davis Executive Vice President of Gen. Diagnostics(age: 62, pay: $1,440,000)
- Ms. Carrie Eglinton Manner Senior Vice President of Advanced Diagnostics(age: 50, pay: $1,310,000)
-
How many employees does Quest Diagnostics Incorporated have?
As Jul 2024, Quest Diagnostics Incorporated employs 50,000 workers, which is 25% more then previous quarter.
-
When Quest Diagnostics Incorporated went public?
Quest Diagnostics Incorporated is publicly traded company for more then 28 years since IPO on 17 Dec 1996.
-
What is Quest Diagnostics Incorporated's official website?
The official website for Quest Diagnostics Incorporated is questdiagnostics.com.
-
Where are Quest Diagnostics Incorporated's headquarters?
Quest Diagnostics Incorporated is headquartered at 500 Plaza Drive, Secaucus, NJ.
-
How can i contact Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated's mailing address is 500 Plaza Drive, Secaucus, NJ and company can be reached via phone at +973 5202700.
-
What is Quest Diagnostics Incorporated stock forecast & price target?
Based on 6 Wall Street analysts` predicted price targets for Quest Diagnostics Incorporated in the last 12 months, the avarage price target is $173.83. The average price target represents a -4.92% change from the last price of $182.83.
Quest Diagnostics Incorporated company profile:
Quest Diagnostics Incorporated
questdiagnostics.comExchange:
NYSE
Full time employees:
50,000
Industry:
Medical - Diagnostics & Research
Sector:
Healthcare
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
500 Plaza Drive
Secaucus, NJ 07094
Secaucus, NJ 07094
CIK: 0001022079
ISIN: US74834L1008
CUSIP: 74834L100
